The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• N6-methyladenosine (m6A) is the most prevalent RNA epigenetic modification in eukaryotic messenger RNAs (mRNAs) and non-coding RNAs (ncRNAs).
• m6A modifications are dynamically regulated by methyltransferases, demethylases, and methyl-binding proteins.
• Aberrant m6A modification patterns are implicated in various physiological processes and are particularly significant in tumor development.

Discussion:

• Dysregulation of m6A modification contributes to abnormal RNA processing, impacting tumor pathogenesis.
• This review explores the intricate mechanisms through which m6A governs mRNA and ncRNA processing within the context of cancer.
• Understanding these regulatory roles is crucial for elucidating m6A's function in tumor cells.

Key Insights:

• m6A modification is a critical regulator of RNA processing in both coding and non-coding RNAs.
• Disruption of m6A homeostasis is linked to abnormal cellular functions and disease states, especially cancer.
• The dynamic nature of m6A allows for intricate control over gene expression relevant to tumorigenesis.

Outlook:

• Further investigation into m6A regulatory networks can reveal novel therapeutic strategies for cancer treatment.
• Targeting m6A pathways may offer new avenues for tumor diagnosis and personalized medicine.
• Continued research on RNA epigenetics, particularly m6A, is essential for advancing cancer research and clinical applications.